Details for Patent: 7,858,118
Summary for Patent: 7,858,118
| Title: | Extended release composition containing Tramadol |
| Abstract: | An oral Tramadol-containing pharmaceutical composition suitable for once daily administration, which contains an amount of Tramadol or a pharmaceutically acceptable salt thereof, providing in vivo, a time of Tramadol peak plasma concentration (Tmax) of greater than 10 hours, and peak Tramadol plasma concentration (Cmax) which are less than three times the plasma concentration obtained 24 hours after administration (C24h) of a single dose of the composition. |
| Inventor(s): | Arthur M. Deboeck, Francis Vanderbist, Antonio Sereno |
| Assignee: | GALEPHAR PHARMACEUTICAL RESEARCH Inc , GALIPHAR PHARMACEUTICAL RESEARCH Inc , Galephar P R Inc Ltd |
| Application Number: | US10/119,939 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 7,858,118
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,858,118
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2002337967 | ⤷ Start Trial | |||
| Canada | 2495463 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2004110410 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
